BACKGROUND: Human respiratory syncytial virus (hRSV) infection causes a spectrum of illnesses ranging from mild infection to life-threatening bronchiolitis and respiratory failure. Human studies on the pathogenesis of RSV infection are invaluable, but animal models permit advances with the use of experimental strategies that would be inappropriate in human studies. METHODS: We review the advantages and disadvantages of various animal models for the study of hRSV infection. RESULTS: No animal model of hRSV infection replicates the complete spectrum of disease severity seen in humans. Available models differ in their ability to incorporate genetic technology and to allow the study of immunity, vaccine efficacy and treatment interventions. Although hRSV establishes disease in primates, this advantage is outweighed by the impracticalities and cost of using such models. The study of bovine RSV infection in calves is appealing because of parallels with human disease. Among rodent models, BALB/c mice have helped delineate the mechanisms underlying vaccine-enhanced RSV disease, and cotton rats have been used for preclinical testing. The single major disadvantage of studying hRSV in rodent models is the limited extent to which this host-restricted human pneumovirus replicates in mouse lung tissue. The rodent-specific Pneumovirus pathogen, pneumonia virus of mice, causes an infection that mirrors severe bronchiolitis and pneumonia in infants infected with RSV, including robust virus replication with profound inflammation. CONCLUSION: The recent development of the pneumonia virus of mice model has permitted exploration of the mechanisms of severe Pneumovirus disease in vivo with the use of sophisticated genetic tools and genetically manipulated mouse strains.
BACKGROUND:Humanrespiratory syncytial virus (hRSV) infection causes a spectrum of illnesses ranging from mild infection to life-threatening bronchiolitis and respiratory failure. Human studies on the pathogenesis of RSV infection are invaluable, but animal models permit advances with the use of experimental strategies that would be inappropriate in human studies. METHODS: We review the advantages and disadvantages of various animal models for the study of hRSV infection. RESULTS: No animal model of hRSV infection replicates the complete spectrum of disease severity seen in humans. Available models differ in their ability to incorporate genetic technology and to allow the study of immunity, vaccine efficacy and treatment interventions. Although hRSV establishes disease in primates, this advantage is outweighed by the impracticalities and cost of using such models. The study of bovine RSV infection in calves is appealing because of parallels with human disease. Among rodent models, BALB/c mice have helped delineate the mechanisms underlying vaccine-enhanced RSV disease, and cotton rats have been used for preclinical testing. The single major disadvantage of studying hRSV in rodent models is the limited extent to which this host-restricted human pneumovirus replicates in mouse lung tissue. The rodent-specific Pneumovirus pathogen, pneumonia virus of mice, causes an infection that mirrors severe bronchiolitis and pneumonia in infants infected with RSV, including robust virus replication with profound inflammation. CONCLUSION: The recent development of the pneumonia virus of mice model has permitted exploration of the mechanisms of severe Pneumovirus disease in vivo with the use of sophisticated genetic tools and genetically manipulated mouse strains.
Authors: Mark J Kwakkenbos; Sean A Diehl; Etsuko Yasuda; Arjen Q Bakker; Caroline M M van Geelen; Michaël V Lukens; Grada M van Bleek; Myra N Widjojoatmodjo; Willy M J M Bogers; Henrik Mei; Andreas Radbruch; Ferenc A Scheeren; Hergen Spits; Tim Beaumont Journal: Nat Med Date: 2009-12-20 Impact factor: 53.440
Authors: A G Randolph; W-K Yip; K Falkenstein-Hagander; S T Weiss; R Janssen; S Keisling; L Bont Journal: Clin Exp Allergy Date: 2014-02 Impact factor: 5.018
Authors: Elske van den Berg; Job B M van Woensel; Albert P Bos; Reinout A Bem; William A Altemeier; Sean E Gill; Thomas R Martin; Gustavo Matute-Bello Journal: Am J Physiol Lung Cell Mol Physiol Date: 2011-07-08 Impact factor: 5.464
Authors: Reinout A Bem; Job B M van Woensel; Albert P Bos; Amy Koski; Alex W Farnand; Joseph B Domachowske; Helene F Rosenberg; Thomas R Martin; Gustavo Matute-Bello Journal: Am J Physiol Lung Cell Mol Physiol Date: 2008-11-07 Impact factor: 5.464
Authors: Jessica S Siegle; Nicole Hansbro; Cristan Herbert; Helene F Rosenberg; Joseph B Domachowske; Kelly L Asquith; Paul S Foster; Rakesh K Kumar Journal: Respir Res Date: 2010-02-03
Authors: Richard Bannister; Deborah Rodrigues; Edward J Murray; Carl Laxton; Mike Westby; Helen Bright Journal: Virol J Date: 2010-09-22 Impact factor: 4.099